Off-Label Use OK When Not Promoted, GSK Exec Says
Prescribing Wellbutrin for off-label uses is fine, GlaxoSmithKline PLC just can't promote the antidepressant for such uses, a company executive testified Wednesday in the Maryland trial of a former GSK attorney...To view the full article, register now.
Already a subscriber? Click here to view full article